Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Edward Partridge

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Concepts & Ideas

Geographic Areas

Alabama

Living Beings

African Americans

Procedures

Anatomy

Cervix Uteri

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Scarinci Isabel C; Johnson Rhoda E; Hardy Claudia; Marron John; Partridge Edward E
Planning and implementation of a participatory evaluation strategy: a viable approach in the evaluation of community-based participatory programs addressing cancer disparities.
Piyathilake Chandrika J; Macaluso Maurizio; Alvarez Ronald D; Bell Walter C; Heimburger Douglas C; Partridge Edward E
Lower risk of cervical intraepithelial neoplasia in women with high plasma folate and sufficient vitamin B12 in the post-folic acid fortification era.
Partridge Edward; Kreimer Aimee R; Greenlee Robert T; Williams Craig; Xu Jian-Lun; Church Timothy R; Kessel Bruce; Johnson Christine C; Weissfeld Joel L; Isaacs Claudine; Andriole Gerald L; Ogden Sheryl; Ragard Lawrence R; Buys Saundra S;
Results from four rounds of ovarian cancer screening in a randomized trial.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Edward Partridge (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Scarinci Isabel C; Johnson Rhoda E; Hardy Claudia; Marron John; Partridge Edward E
Planning and implementation of a participatory evaluation strategy: a viable approach in the evaluation of community-based participatory programs addressing cancer disparities.
Evaluation and program planning 2009;32(3):221-8.
2009: Piyathilake Chandrika J; Macaluso Maurizio; Alvarez Ronald D; Bell Walter C; Heimburger Douglas C; Partridge Edward E
Lower risk of cervical intraepithelial neoplasia in women with high plasma folate and sufficient vitamin B12 in the post-folic acid fortification era.
Cancer prevention research (Philadelphia, Pa.) 2009;2(7):658-64.
2009: Partridge Edward; Kreimer Aimee R; Greenlee Robert T; Williams Craig; Xu Jian-Lun; Church Timothy R; Kessel Bruce; Johnson Christine C; Weissfeld Joel L; Isaacs Claudine; Andriole Gerald L; Ogden Sheryl; Ragard Lawrence R; Buys Saundra S;
Results from four rounds of ovarian cancer screening in a randomized trial.
Obstetrics and gynecology 2009;113(4):775-82.
2008: Lisovicz Nedra; Wynn Theresa; Fouad Mona; Partridge Edward E
Cancer health disparities: what we have done.
The American journal of the medical sciences 2008;335(4):254-9.
2007: Scarinci Isabel C; Garcés-Palacio Isabel C; Partridge Edward E
An examination of acceptability of HPV vaccination among African American women and Latina immigrants.
Journal of women's health (2002) 2007;16(8):1224-33.
2007: Leath C A; Numnum T M; Straughn J M; Rocconi R P; Huh W K; Kilgore L C; Partridge E E
Outcomes for patients with fallopian tube carcinoma managed with adjuvant chemotherapy following primary surgery: a retrospective university experience.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2007;17(5):998-1002.
2007: Case Ashley S; Rocconi Rodney P; Partridge Edward E; Straughn J Michael
A cost-effectiveness analysis of chemotherapy for patients with recurrent platinum-sensitive epithelial ovarian cancer.
Gynecologic oncology 2007;105(1):223-7.
2007: Piyathilake Chandrika J; Azrad Maria; Macaluso Maurizio; Johanning Gary L; Cornwell Phillip E; Partridge Edward E; Heimburger Douglas C
Protective association of MTHFR polymorphism on cervical intraepithelial neoplasia is modified by riboflavin status.
Nutrition (Burbank, Los Angeles County, Calif.) 2007;23(3):229-35.
2007: Piyathilake Chandrika J; Macaluso Maurizio; Brill Ilene; Heimburger Douglas C; Partridge Edward E
Lower red blood cell folate enhances the HPV-16-associated risk of cervical intraepithelial neoplasia.
Nutrition (Burbank, Los Angeles County, Calif.) 2007;23(3):203-10.
2007: Dietrich C S; Desimone C P; Modesitt S C; Depriest P D; Ueland F R; Pavlik E J; Kryscio R; Cibull M; Huh W; Partridge E; Numnum T M; Schilder J; Higgins R V; van Nagell J R
Primary appendiceal cancer: gynecologic manifestations and treatment options.
Gynecologic oncology 2007;104(3):602-6.
2007: Spannuth Whitney A; Leath Charles A; Huh Warner K; Barnes Mack N; Davidson Susan A; Kilgore Larry C; Partridge Edward E; Austin J Maxwell; Alvarez Ronald D
A phase II trial of weekly topotecan for patients with secondary platinum-resistant recurrent epithelial ovarian carcinoma following the failure of second-line therapy.
Gynecologic oncology 2007;104(3):591-5.
2006: Lisovicz Nedra; Johnson Rhoda E; Higginbotham John; Downey Jennifer A; Hardy Claudia M; Fouad Mona N; Hinton Agnes W; Partridge Edward E
The Deep South Network for cancer control. Building a community infrastructure to reduce cancer health disparities.
Cancer 2006;107(8 Suppl):1971-9.
2006: Rocconi Rodney P; Case Ashley S; Straughn J Michael; Estes Jacob M; Partridge Edward E
Role of chemotherapy for patients with recurrent platinum-resistant advanced epithelial ovarian cancer: A cost-effectiveness analysis.
Cancer 2006;107(3):536-43.
2006: Wynn Theresa Ann; Johnson Rhoda E; Fouad Mona; Holt Cheryl; Scarinci Isabel; Nagy Christine; Partridge Edward; Dignan Mark B; Person Sharina; Parham Groesbeck
Addressing disparities through coalition building: Alabama REACH 2010 lessons learned.
Journal of health care for the poor and underserved 2006;17(2 Suppl):55-77.
2006: Rocconi Rodney P; Straughn J Michael; Leath Charles A; Kilgore Larry C; Huh Warner K; Barnes Mack N; Partridge Edward E; Alvarez Ronald D
Pegylated liposomal doxorubicin consolidation therapy after platinum/paclitaxel-based chemotherapy for suboptimally debulked, advanced-stage epithelial ovarian cancer patients.
The oncologist 2006;11(4):336-41.
2006: Fouad Mona N; Partridge Edward; Dignan Mark; Holt Cheryl; Johnson Rhoda; Nagy Christine; Parham Groesbeck; Person Sharina; Scarinci Isabel; Wynn Theresa
A community-driven action plan to eliminate breast and cervical cancer disparity: successes and limitations.
Journal of cancer education : the official journal of the American Association for Cancer Education 2006;21(1 Suppl):S91-100.
2005: Straughn J Michael; Numnum T Michael; Kilgore Larry C; Partridge Edward E; Phillips Jerri Linn; Markman Maurie; Thomas Gillian M; Burke Thomas W;
The use of adjuvant radiation therapy in patients with intermediate-risk Stages IC and II uterine corpus cancer: a patient care evaluation study from the American College of Surgeons National Cancer Data Base.
Gynecologic oncology 2005;99(3):530-5.
2005: Buys Saundra S; Partridge Edward; Greene Mark H; Prorok Philip C; Reding Douglas; Riley Thomas L; Hartge Patricia; Fagerstrom Richard M; Ragard Lawrence R; Chia David; Izmirlian Grant; Fouad Mona; Johnson Christine C; Gohagan John K;
Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial.
American journal of obstetrics and gynecology 2005;193(5):1630-9.
2005: Leath Charles A; Straughn J Michael; Kirby Tyler O; Huggins Adam; Partridge Edward E; Parham Groesbeck P
Predictors of outcomes for women with cervical carcinoma.
Gynecologic oncology 2005;99(2):432-6.
2005: Barnes Mack N; Chhieng David F; Dreher Mackenzie; Jones Jennifer L; Grizzle William E; Jones Laura; Talley Lynya; Partridge Edward E
Feasibility of performing chemoprevention trials in women at elevated risk of ovarian carcinoma: initial examination of celecoxib as a chemopreventive agent.
Gynecologic oncology 2005;98(3):376-82.
2005: Eltoum Isam A; Chhieng David C; Roberson Janie; McMillon Drew; Partridge Edward E
Reflex human papilloma virus infection testing detects the same proportion of cervical intraepithelial neoplasia grade 2-3 in young versus elderly women.
Cancer 2005;105(4):194-8.
2005: Henao Olga L; Piyathilake Chandrika J; Waterbor John W; Funkhouser Ellen; Johanning Gary L; Heimburger Douglas C; Partridge Edward E
Women with polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase (MS) are less likely to have cervical intraepithelial neoplasia (CIN) 2 or 3.
International journal of cancer. Journal international du cancer 2005;113(6):991-7.
2005: Partridge Edward E; Fouad Mona N; Hinton Agnes W; Hardy Claudia M; Liscovicz Nedra; White-Johnson Freddie; Higginbotham John C
The deep South network for cancer control: eliminating cancer disparities through community-academic collaboration.
Family & community health 2005;28(1):6-19.
2004: Piyathilake Chandrika J; Henao Olga L; Macaluso Maurizio; Cornwell Phillip E; Meleth Sreelatha; Heimburger Douglas C; Partridge Edward E
Folate is associated with the natural history of high-risk human papillomaviruses.
Cancer research 2004;64(23):8788-93.
2004: Straughn J Michael; Numnum T Michael; Rocconi Rodney P; Leath Charles A; Partridge Edward E
A cost-effectiveness analysis of screening strategies for cervical intraepithelial neoplasia.
Journal of lower genital tract disease 2004;8(4):280-4.
2004: Leath Charles A; Straughn J Michael; Conner Michael G; Barnes Mack N; Alvarez Ronald D; Partridge Edward E; Huh Warner K
Immunohistochemical evaluation of the c-kit proto-oncogene in sarcomas of the uterus: a case series.
The Journal of reproductive medicine 2004;49(2):71-5.
2004: Leath Charles A; Straughn J Michael; Bhoola Snehal M; Partridge Edward E; Kilgore Larry C; Alvarez Ronald D
The role of radical parametrectomy in the treatment of occult cervical carcinoma after extrafascial hysterectomy.
Gynecologic oncology 2004;92(1):215-9.
2004: Fouad Mona N; Nagy M Christine; Johnson Rhoda E; Wynn Theresa A; Partridge Edward E; Dignan Mark
The development of a community action plan to reduce breast and cervical cancer disparities between African-American and White women.
Ethnicity & disease 2004;14(3 Suppl 1):S53-60.
2003: Huh Warner K; Powell Matthew; Leath Charles A; Straughn J Michael; Cohn David E; Gold Michael A; Falkner Camille A; Carey Delicia E; Herzog Thomas; Fowler Jeffrey M; Partridge Edward E; Kilgore Larry C; Alvarez Ronald D
Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy.
Gynecologic oncology 2003;91(3):470-5.
2003: Chhieng David C; Rodriguez-Burford Cristina; Talley Lynya I; Sviglin Helena; Stockard Cecil R; Kleinberg Marc J; Barnes Mack N; Partridge Edward E; Khazaeli M B; Grizzle William E
Expression of CEA, Tag-72, and Lewis-Y antigen in primary and metastatic lesions of ovarian carcinoma.
Human pathology 2003;34(10):1016-21.
2003: Kirby T O; Huh W K; Partridge E E
Human papillomavirus triage of patients with atypical squamous cells of undetermined significance on cervical Papanicolaou smear.
Annals of the Academy of Medicine, Singapore 2003;32(5):590-5; quiz 596.
2003: Kleinberg Marc J; Straughn J Michael; Stringer Jeffery S A; Partridge Edward E
A cost-effectiveness analysis of management strategies for cervical intraepithelial neoplasia grades 2 and 3.
American journal of obstetrics and gynecology 2003;188(5):1186-8.
2003: Straughn J Michael; Huh Warner K; Orr James W; Kelly F Joseph; Roland Phillip Y; Gold Michael A; Powell Matthew; Mutch David G; Partridge Edward E; Kilgore Larry C; Barnes Mack N; Austin J Maxwell; Alvarez Ronald D
Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy.
Gynecologic oncology 2003;89(2):295-300.
2003: Chaudhuri Tandra R; Cao Zhihong; Krasnykh Victor N; Stargel Amanda V; Belousova Natalya; Partridge Edward E; Zinn Kurt R
Blood-based screening and light based imaging for the early detection and monitoring of ovarian cancer xenografts.
Technology in cancer research & treatment 2003;2(2):171-80.
2003: Rodríguez-Burford C; Oelschlager D K; Talley L I; Barnes M N; Partridge E E; Grizzle W E
The use of dimethylsulfoxide as a vehicle in cell culture experiments using ovarian carcinoma cell lines.
Biotechnic & histochemistry : official publication of the Biological Stain Commission 2003;78(1):17-21.
2003: Rodríguez-Burford Cristina; Chhieng David C; Stockard Cecil R; Kleinberg Marc J; Barnes Mack N; Partridge Edward E; Weiss Heidi L; Grizzle William E
p53 and erbB-2 are not associated in matched cases of primary and metastatic ovarian carcinomas.
Disease markers 2003;19(1):11-7.
2002: Barnes Mack N; Berry Wallace D; Straughn J Michael J; Kirby Tyler O; Leath Charles A; Huh Warner K; Grizzle William E; Partridge Edward E
A pilot study of ovarian cancer chemoprevention using medroxyprogesterone acetate in an avian model of spontaneous ovarian carcinogenesis.
Gynecologic oncology 2002;87(1):57-63.
2002: Alvarez Ronald D; Huh Warner K; Khazaeli M B; Meredith Ruby F; Partridge Edward E; Kilgore Larry C; Grizzle William E; Shen Sui; Austin J Max; Barnes Mack N; Carey Delicia; Schlom Jeffrey; LoBuglio Albert F
A Phase I study of combined modality (90)Yttrium-CC49 intraperitoneal radioimmunotherapy for ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(9):2806-11.
2002: Donovan Kristine A; Greene Paul G; Shuster John L; Partridge Edward E; Tucker Diane C
Treatment preferences in recurrent ovarian cancer.
Gynecologic oncology 2002;86(2):200-11.
2002: Barnes Mack N; Grizzle William E; Grubbs Clinton J; Partridge Edward E
Paradigms for primary prevention of ovarian carcinoma.
CA: a cancer journal for clinicians 2002;52(4):216-25.
2002: Straughn J Michael; Huh Warner K; Kelly F Joseph; Leath Charles A; Kleinberg Marc J; Hyde Johnny; Numnum T Michael; Zhang Yuting; Soong Seng-Jaw; Austin J Maxwell; Partridge Edward E; Kilgore Larry C; Alvarez Ronald D
Conservative management of stage I endometrial carcinoma after surgical staging.
Gynecologic oncology 2002;84(2):194-200.
2002: Rodríguez-Burford Cristina; Barnes Mack N; Oelschlager Denise K; Myers Russell B; Talley Lynya I; Partridge Edward E; Grizzle William E
Effects of nonsteroidal anti-inflammatory agents (NSAIDs) on ovarian carcinoma cell lines: preclinical evaluation of NSAIDs as chemopreventive agents.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(1):202-9.
2001: Chaudhuri T R; Mountz J M; Rogers B E; Partridge E E; Zinn K R
Light-based imaging of green fluorescent protein-positive ovarian cancer xenografts during therapy.
Gynecologic oncology 2001;82(3):581-9.
2001: Meredith R F; Alvarez R D; Partridge E E; Khazaeli M B; Lin C Y; Macey D J; Austin J M; Kilgore L C; Grizzle W E; Schlom J; LoBuglio A F
Intraperitoneal radioimmunochemotherapy of ovarian cancer: a phase I study.
Cancer biotherapy & radiopharmaceuticals 2001;16(4):305-15.
2001: Rodríguez-Burford C; Barnes M N; Berry W; Partridge E E; Grizzle W E
Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention.
Gynecologic oncology 2001;81(3):373-9.
2001: Fouad M N; Partridge E; Wynn T; Green B L; Kohler C; Nagy S
Statewide Tuskegee Alliance for clinical trials. A community coalition to enhance minority participation in medical research.
Cancer 2001;91(1 Suppl):237-41.
2000: Fouad M N; Partridge E; Green B L; Kohler C; Wynn T; Nagy S; Churchill S
Minority recruitment in clinical trials: a conference at Tuskegee, researchers and the community.
Annals of epidemiology 2000;10(8 Suppl):S35-40.
2000: Partridge E E
Differentiation between the sick and the dying: an ancient art forgotten in modern medicine.
Gynecologic oncology 2000;79(1):1-3.
2000: Straughn J M; Robertson M W; Partridge E E
A patient presenting with a pelvic mass, elevated CA-125, and fever.
Gynecologic oncology 2000;77(3):471-2.
2000: Green B L; Partridge E E; Fouad M N; Kohler C; Crayton E F; Alexander L
African-American attitudes regarding cancer clinical trials and research studies: results from focus group methodology.
Ethnicity & disease 2000;10(1):76-86.
1999: Bajaj P K; Barnes M N; Robertson M W; Shah P; Austin J M; Partridge E E; Austin J M
Surgical management of endometrial adenocarcinoma using laparoscopically assisted staging and treatment.
Southern medical journal 1999;92(12):1174-7.
1999: Partridge E E; Barnes M N
Epithelial ovarian cancer: prevention, diagnosis, and treatment.
CA: a cancer journal for clinicians 1999;49(5):297-320.
1999: Barnes M N; Roland P Y; Straughn M; Kilgore L C; Alvarez R D; Partridge E E
A comparison of treatment strategies for endometrial adenocarcinoma: analysis of financial impact.
Gynecologic oncology 1999;74(3):443-7.
1998: Naumann R W; Alvarez R D; Omura G A; Segars E; Kilgore L C; Partridge E E
A phase I study of paclitaxel, doxorubicin, and cisplatin in patients with previously untreated epithelial ovarian cancer.
Gynecologic oncology 1998;71(3):450-3.
1998: Roland P Y; Barnes M N; Niwas S; Robertson M W; Alvarez R; Austin J M; Kilgore L C; Partridge E E
Response to salvage treatment in recurrent ovarian cancer treated initially with paclitaxel and platinum-based combination regimens.
Gynecologic oncology 1998;68(2):178-82.
1997: Weiss H L; Soong S J; Partridge E E; Carpenter J; Bryant B; Waterbor J W
Cancer incidence among predominantly black, rural-poor populations in southern states.
Southern medical journal 1997;90(10):986-92.
1997: Alvarez R D; Partridge E E; Khazaeli M B; Plott G; Austin M; Kilgore L; Russell C D; Liu T; Grizzle W E; Schlom J; LoBuglio A F; Meredith R F
Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II study.
Gynecologic oncology 1997;65(1):94-101.
1997: Berner E S; Partridge E E; Baum S K
The effects of the PDQ patient information file (PIF) on patients' knowledge, enrollment in clinical trials, and satisfaction.
Journal of cancer education : the official journal of the American Association for Cancer Education 1997;12(2):121-5.
1996: Partridge E E; Phillips J L; Menck H R
The National Cancer Data Base report on ovarian cancer treatment in United States hospitals.
Cancer 1996;78(10):2236-46.
1996: Naumann R W; Crispens M A; Alvarez R D; Partridge E E; Shingleton H M; Kilgore L C
Treatment of cervical dysplasia with large loop excision of the transformation zone: is endocervical curettage necessary?
Southern medical journal 1996;89(10):961-5.
1996: Meredith R F; Partridge E E; Alvarez R D; Khazaeli M B; Plott G; Russell C D; Wheeler R H; Liu T; Grizzle W E; Schlom J; LoBuglio A F
Intraperitoneal radioimmunotherapy of ovarian cancer with lutetium-177-CC49.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(9):1491-6.
1996: Edwards R P; Pitts A; Crowley-Nowick P; Partridge E E; Gore H; Mestecky J
Immunoglobulin-containing plasma cells recruited to cervical neoplasia.
Obstetrics and gynecology 1996;87(4):520-6.
1995: Siller B S; Gelder M S; Alvarez R D; Partridge E E
Massive edema of the ovary associated with androgenic manifestations.
Southern medical journal 1995;88(11):1153-5.
1995: Edwards R P; Kuykendall K; Crowley-Nowick P; Partridge E E; Shingleton H M; Mestecky J
T lymphocytes infiltrating advanced grades of cervical neoplasia. CD8-positive cells are recruited to invasion.
Cancer 1995;76(8):1411-5.
1995: Crowley-Nowick P A; Bell M; Edwards R P; McCallister D; Gore H; Kanbour-Shakir A; Mestecky J; Partridge E E
Normal uterine cervix: characterization of isolated lymphocyte phenotypes and immunoglobulin secretion.
American journal of reproductive immunology (New York, N.Y. : 1989) 1995;34(4):241-7.
1995: Roland P Y; Naumann R W; Alvarez R D; Kilgore L C; Partridge E E
A decision analysis of practice patterns used in evaluating and treating abnormal Pap smears.
Gynecologic oncology 1995;59(1):75-80.
1995: Siller B S; Alvarez R D; Conner W D; McCullough C H; Kilgore L C; Partridge E E; Austin J M
T2/3 vulva cancer: a case-control study of triple incision versus en bloc radical vulvectomy and inguinal lymphadenectomy.
Gynecologic oncology 1995;57(3):335-9.
1995: Bell M C; Edwards R P; Partridge E E; Kuykendall K; Conner W; Gore H; Turbat-Herrara E; Crowley-Nowick P A
CD8+ T lymphocytes are recruited to neoplastic cervix.
Journal of clinical immunology 1995;15(3):130-6.
1995: Kilgore L C; Partridge E E; Alvarez R D; Austin J M; Shingleton H M; Noojin F; Conner W
Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling.
Gynecologic oncology 1995;56(1):29-33.
1994: Naumann R W; Bell M C; Alvarez R D; Edwards R P; Partridge E E; Helm C W; Shingleton H M; McGee J A; Higgins R V; Hall J B
LLETZ is an acceptable alternative to diagnostic cold-knife conization.
Gynecologic oncology 1994;55(2):224-8.
1994: Higgins R V; Hall J B; McGee J A; Laurent S; Alvarez R D; Partridge E E
Appraisal of the modalities used to evaluate an initial abnormal Papanicolaou smear.
Obstetrics and gynecology 1994;84(2):174-8.
1994: Alvarez R D; Helm C W; Edwards R P; Naumann R W; Partridge E E; Shingleton H M; McGee J A; Hall J B; Higgins R V; Malone J M
Prospective randomized trial of LLETZ versus laser ablation in patients with cervical intraepithelial neoplasia.
Gynecologic oncology 1994;52(2):175-9.
1993: Alvarez R D; Kilgore L C; Partridge E E; Austin J M; Shingleton H M
Staging ovarian cancer diagnosed during laparoscopy: accuracy rather than immediacy.
Southern medical journal 1993;86(11):1256-8.
1993: Gelder M S; Alvarez R D; Partridge E E
Ureteroarterial fistulae in exenteration patients with indwelling ureteral stents.
Gynecologic oncology 1993;50(3):365-70.
1993: Naumann R W; Alvarez R D; Partridge E E; Kilgore L C; Austin J M
The Groshong catheter as an intraperitoneal access device in the treatment of ovarian cancer patients.
Gynecologic oncology 1993;50(3):291-3.
1993: Helm C W; Hatch K D; Partridge E E; Shingleton H M
The rhomboid transposition flap for repair of the perineal defect after radical vulvar surgery.
Gynecologic oncology 1993;50(2):164-7.
1993: Alvarez R D; Gelder M S; Gore H; Soong S J; Partridge E E
Radical hysterectomy in the treatment of patients with bulky early stage carcinoma of the cervix uteri.
Surgery, gynecology & obstetrics 1993;176(6):539-42.
1993: Partridge E E; Gunter B C; Gelder M S; Alvarez R D; Soong S J; Austin J M; Kilgore L C
The validity and significance of substages of advanced ovarian cancer.
Gynecologic oncology 1993;48(2):236-41.
1992: Helm C W; Hatch K; Austin J M; Partridge E E; Soong S J; Elder J E; Shingleton H M
A matched comparison of single and triple incision techniques for the surgical treatment of carcinoma of the vulva.
Gynecologic oncology 1992;46(2):150-6.
1992: Gallion H H; Hunter J E; van Nagell J R; Averette H E; Cain J M; Copeland L J; Higgins R V; Husseinzadeh N; Nahhas W A; Partridge E E
The prognostic implications of low serum CA 125 levels prior to the second-look operation for stage III and IV epithelial ovarian cancer.
Gynecologic oncology 1992;46(1):29-32.
1992: Dyas C H; Simmons T K; Ellis C N; Austin J M; Partridge E E; Kilgore L C; Reading C; Nelson K; Blakemore W S
Effect of deoxyribonucleic acid ploidy status on survival of patients with carcinoma of the endometrium.
Surgery, gynecology & obstetrics 1992;174(2):133-6.
1992: Potter M E; Hatch K D; Soong S J; Partridge E E; Austin J M; Shingleton H M
Second-look laparotomy and salvage therapy: a research modality only?
Gynecologic oncology 1992;44(1):3-9.
1991: Alvarez R D; Gleason B P; Gore H; Partridge E E
Coexisting intraductal breast carcinoma and metastatic choriocarcinoma presenting as a breast mass.
Gynecologic oncology 1991;43(3):295-9.
1991: Alvarez R D; Potter M E; Soong S J; Gay F L; Hatch K D; Partridge E E; Shingleton H M
Rationale for using pathologic tumor dimensions and nodal status to subclassify surgically treated stage IB cervical cancer patients.
Gynecologic oncology 1991;43(2):108-12.
1991: Potter M E; Partridge E E; Hatch K D; Soong S J; Austin J M; Shingleton H M
Primary surgical therapy of ovarian cancer: how much and when.
Gynecologic oncology 1991;40(3):195-200.
1990: Patsner B; Orr J W; Mann W J; Taylor P T; Partridge E; Allmen T
Does serum CA-125 level prior to second-look laparotomy for invasive ovarian adenocarcinoma predict size of residual disease?
Gynecologic oncology 1990;38(3):373-6.
1990: Patsner B; Orr J W; Mann W J; Taylor P T; Partridge E; Allmen T
Does serum CA-125 level prior to second-look laparotomy for invasive ovarian adenocarcinoma predict size of residual disease?
Gynecologic oncology 1990;37(3):319-22.
1989: Potter M E; Partridge E E; Shingleton H M; Soong S J; Kim R Y; Hatch K D; Austin J M
Intraperitoneal chromic phosphate in ovarian cancer: risks and benefits.
Gynecologic oncology 1989;32(3):314-8.
1988: Kilgore L C; Soong S J; Gore H; Shingleton H M; Hatch K D; Partridge E E
Analysis of prognostic features in adenocarcinoma of the cervix.
Gynecologic oncology 1988;31(1):137-53.
1986: Orr J W; Ball G C; Soong S J; Hatch K D; Partridge E E; Austin J M
Surgical treatment of women found to have invasive cervix cancer at the time of total hysterectomy.
Obstetrics and gynecology 1986;68(3):353-6.
1983: Orr J W; Shingleton H M; Soong S J; Hatch K D; Bryant J W; Partridge E E; Austin J M; Taylor P T; Pearce S C
Hemodynamic parameters following pelvic exenteration.
American journal of obstetrics and gynecology 1983;146(8):882-92.
1983: Orr J W; Shingleton H M; Hatch K D; Taylor P T; Partridge E E; Soong S J
Gastrointestinal complications associated with pelvic exenteration.
American journal of obstetrics and gynecology 1983;145(3):325-32.
1982: Orr J W; Shingleton H M; Hatch K D; Taylor P T; Austin J M; Partridge E E; Soong S J
Urinary diversion in patients undergoing pelvic exenteration.
American journal of obstetrics and gynecology 1982;142(7):883-9.
1981: Mann W J; Orr J W; Shingleton H M; Austin J M; Hatch K D; Taylor P T; Partridge E; Soong S J
Perioperative influences on infectious morbidity in radical hysterectomy.
Gynecologic oncology 1981;11(2):207-12.
1980: Mann W J; Jander H P; Partridge E E; Russinovich N; Hatch K D; Taylor P T; Shingleton H M
Selective arterial embolization for control of bleeding in gynecologic malignancy.
Gynecologic oncology 1980;10(3):279-89.
1980: Partridge E E; Murad T; Shingleton H M; Austin J M; Hatch K D
Verrucous lesions of the female genitalia. II. Verrucous carcinoma.
American journal of obstetrics and gynecology 1980;137(4):419-24.
1980: Partridge E E; Murad T; Shingleton H M; Austin J M; Hatch K D
Verrucous lesions of the female genitalia. I. Giant condylomata.
American journal of obstetrics and gynecology 1980;137(4):412-8.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Edward Partridge

Research Profile (preview)

Disorders

Concepts & Ideas

Geographic Areas

Living Beings

Procedures

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Edward Partridge (preview)

All Publications